Literature DB >> 15124087

Scutellarin attenuates oxidative glutamate toxicity in PC12 cells.

Hao Hong1, Guo-Qing Liu.   

Abstract

The present study investigated the protective effects of the antioxidant scutellarin against oxidative toxicity induced by glutamate in PC12 cells. Vitamin E, a classical antioxidant was employed as a comparative agent. Incubation of PC12 cells with 10 mM glutamate resulted in significant cytotoxity as evaluated by the MTT and lactate dehydrogenase (LDH) assays, decreases of GSSG reductase activity, disturbance of the cell redox state as indicated by the GSH/GSSG ratio, and accumulation of intracellular reactive oxygen species (ROS) and lipid peroxidation products. Scutellarin at 0.1, 1 and 10 microM significantly protected against the cytoxicity and production of ROS and lipid peroxidation induced by glutamate. Scutellarin did not prevent the reduction of cellular GSH levels, but it up-regulated GSSG reductase activity, thus preventing an increase in cellular GSSG levels, and concomitantly improved the cell redox status. Our data also show that the protective effects of scutellarin against glutamate-induced oxidative toxicity are more potent than that of vitamin E. These results demonstrate that scutellarin can protect PC12 cells from oxidative glutamate toxicity by scavenging ROS, inhibiting lipid peroxidation and improving the cell redox status, and may reduce the cellular damage in pathological conditions associated with excessive glutamate release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15124087     DOI: 10.1055/s-2004-818970

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

1.  Synthesis of caffeic acid sulfonamide derivatives and their protective effect against H2O2 induced oxidative damage in A549 cells.

Authors:  Xiaoyu Peng; Tingjun Hu; Yuxue Zhang; Anran Zhao; Bharathi Natarajan; Jiata Wei; Hao Yan; Hailan Chen; Cuiwu Lin
Journal:  RSC Adv       Date:  2020-03-09       Impact factor: 4.036

2.  A new and practical synthetic method for the synthesis of 6-O-methyl-scutellarein: one metabolite of scutellarin in vivo.

Authors:  Hang Lin; Wei Zhang; Ze-Xi Dong; Ting Gu; Nian-Guang Li; Zhi-Hao Shi; Jun Kai; Cheng Qu; Guan-Xiong Shang; Yu-Ping Tang; Fang Fang; He-Min Li; Jian-Ping Yang; Jin-Ao Duan
Journal:  Int J Mol Sci       Date:  2015-04-03       Impact factor: 5.923

Review 3.  Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: a systematic review and a meta-analysis of Chinese studies.

Authors:  Chanjiao Zheng; Weilin Ou; Huanyu Shen; Zhiheng Zhou; Jiaji Wang
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

4.  Breviscapine Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Rats After Coronary Microembolization by Activating the PI3K/Akt/GSK-3β Signaling Pathway.

Authors:  Zhi-Qing Chen; You Zhou; Feng Chen; Jun-Wen Huang; Jing Zheng; Hao-Liang Li; Tao Li; Lang Li
Journal:  Drug Des Devel Ther       Date:  2021-02-25       Impact factor: 4.162

5.  Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.

Authors:  Daniel M Shadrack; Egid B Mubofu; Stephen S Nyandoro
Journal:  Int J Mol Sci       Date:  2015-11-04       Impact factor: 5.923

6.  Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury.

Authors:  Jing-Bo Sun; Yan Li; Ye-Feng Cai; Yan Huang; Shu Liu; Patrick Kk Yeung; Min-Zhen Deng; Guang-Shun Sun; Prince Lm Zilundu; Qian-Sheng Hu; Rui-Xin An; Li-Hua Zhou; Li-Xin Wang; Xiao Cheng
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.